Hormonal
Daily subcutaneous liraglutide at 3.0 mg significantly increases weight loss in overweight or obese adults with type 2 diabetes compared to placebo when used as an adjunct to lifestyle interventions.
If you have type 2 diabetes and are overweight, adding daily liraglutide (3.0 mg) to your current diet and exercise plan can lead to significant weight loss (about 6% of body weight over 56 weeks) compared to diet and exercise alone. This medication works by reducing appetite. You should discuss the benefits and potential side effects, such as gastrointestinal issues, with your healthcare provider.
Among overweight and obese participants with type 2 diabetes, use of subcutaneous liraglutide (3.0 mg) daily, compared with placebo, resulted in weight loss over 56 weeks.
Why this rating
Large-scale, randomized, double-blind, placebo-controlled trial with 846 participants across 9 countries.
Source
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
Melanie J. Davies et al. · JAMA · 2015
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →